psychedelics-investing Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
psychedelics-investing Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy
psychedelics-investing Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition
psychedelics-investing Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto
psychedelics-investing Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia & Company
psychedelics-investing Lobe Sciences Announces Additional Details Regarding the Acquisition of Altemia & Company
psychedelics-investing Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia
pharmaceutical-investing Orphan Drug Development an Exciting Opportunity to Provide Superior Therapeutics, Lobe Sciences CEO Says
CORRECTION - Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound
